Immunomodulation Therapies for Atherosclerosis: The Past, the Present, and the Future
Atherosclerotic cardiovascular disease is the most common cause of morbidity and death worldwide. Recent studies have demonstrated that this chronic inflammatory disease of the arterial wall can be controlled through the modulation of immune system activity. Many patients with cardiovascular disease...
Main Authors: | Dalgisio Lecis, Gianluca Massaro, Daniela Benedetto, Marco Di Luozzo, Giulio Russo, Alessandro Mauriello, Massimo Federici, Giuseppe Massimo Sangiorgi |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-07-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/24/13/10979 |
Similar Items
-
Beyond the Cardiovascular Effects of Glucagon-like Peptide-1 Receptor Agonists: Body Slimming and Plaque Stabilization. Are New Statins Born?
by: Dalgisio Lecis, et al.
Published: (2023-11-01) -
Gut Microbiota Composition and Cardiovascular Disease: A Potential New Therapeutic Target?
by: Martina Belli, et al.
Published: (2023-07-01) -
SARS-CoV-2 and Atherosclerosis: Should COVID-19 Be Recognized as a New Predisposing Cardiovascular Risk Factor?
by: Mattia Vinciguerra, et al.
Published: (2021-10-01) -
STUDYING OF APPLICATION IMMUNOMODULATOR «GALAVIT» AT EXPERIMENTAL ATHEROSCLEROSIS
by: E. P. Turmova, et al.
Published: (2012-05-01) -
Autologous Immune Cell-Based Regenerative Therapies to Treat Vasculogenic Erectile Dysfunction: Is the Immuno-Centric Revolution Ready for the Prime Time?
by: Michela Bonanni, et al.
Published: (2022-05-01)